Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 6Breast Neoplasms 4Thyroid Neoplasms 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Carcinoma, Hepatocellular 2Adenocarcinoma Of Esophagus 2Uterine Cervical Neoplasms 1Thyroid Diseases 1Thyroid Cancer, Papillary 1Thoracic Diseases 1Stage I Prostate Adenocarcinoma AJCC v7 1Seroma 1Sarcoma, Ewing 1Salivary Gland Neoplasms 1Recurrence 1Polycystic Ovary Syndrome 1Parathyroid Neoplasms 1Parathyroid Diseases 1Pancreatic Neoplasms 1Oropharyngeal Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Lymphatic Metastasis 1Lung Neoplasms 1Liver Neoplasms 1Leukemia, Myeloid, Acute 1Kidney Neoplasms 1Infertility 1

Interventions

Magnetic Resonance Spectroscopy 4olaparib 1gallium 68 PSMA-11 1durvalumab 1X-Rays 1Specimen Handling 1Radiation 1Photons 1Lutetium-177 1Immunoglobulin G 1Disulfides 1Congresses as Topic 168Ga-DKFZ-PSMA-11 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Biochemically Recurrent Prostate Carcinoma × Congresses as Topic × Clear all
NCT06105918 2025-12-09

Radioligand Therapy After PSMA PET Guided External Beam Radiotherapy for Treating Post-Prostatectomy Patients With Biochemically Recurrent Prostate Cancer

Emory University

Phase 1 Active not recruiting
6 enrolled
Genitourinary

Biochemically Recurrent Prostate Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡